355 related articles for article (PubMed ID: 29785028)
1. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia.
Beekman R; Chapaprieta V; Russiñol N; Vilarrasa-Blasi R; Verdaguer-Dot N; Martens JHA; Duran-Ferrer M; Kulis M; Serra F; Javierre BM; Wingett SW; Clot G; Queirós AC; Castellano G; Blanc J; Gut M; Merkel A; Heath S; Vlasova A; Ullrich S; Palumbo E; Enjuanes A; Martín-García D; Beà S; Pinyol M; Aymerich M; Royo R; Puiggros M; Torrents D; Datta A; Lowy E; Kostadima M; Roller M; Clarke L; Flicek P; Agirre X; Prosper F; Baumann T; Delgado J; López-Guillermo A; Fraser P; Yaspo ML; Guigó R; Siebert R; Martí-Renom MA; Puente XS; López-Otín C; Gut I; Stunnenberg HG; Campo E; Martin-Subero JI
Nat Med; 2018 Jun; 24(6):868-880. PubMed ID: 29785028
[TBL] [Abstract][Full Text] [Related]
2. Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics.
Speedy HE; Beekman R; Chapaprieta V; Orlando G; Law PJ; Martín-García D; Gutiérrez-Abril J; Catovsky D; Beà S; Clot G; Puiggròs M; Torrents D; Puente XS; Allan JM; López-Otín C; Campo E; Houlston RS; Martín-Subero JI
Nat Commun; 2019 Aug; 10(1):3615. PubMed ID: 31399598
[TBL] [Abstract][Full Text] [Related]
3. Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks.
Rendeiro AF; Schmidl C; Strefford JC; Walewska R; Davis Z; Farlik M; Oscier D; Bock C
Nat Commun; 2016 Jun; 7():11938. PubMed ID: 27346425
[TBL] [Abstract][Full Text] [Related]
4. IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.
Nadeu F; Royo R; Clot G; Duran-Ferrer M; Navarro A; Martín S; Lu J; Zenz T; Baumann T; Jares P; Puente XS; Martín-Subero JI; Delgado J; Campo E
Blood; 2021 May; 137(21):2935-2946. PubMed ID: 33211804
[TBL] [Abstract][Full Text] [Related]
5. Chromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset 8-specific signature.
Tsagiopoulou M; Chapaprieta V; Russiñol N; García-Torre B; Pechlivanis N; Nadeu F; Papakonstantinou N; Stavroyianni N; Chatzidimitriou A; Psomopoulos F; Campo E; Stamatopoulos K; Martín-Subero JI
Blood; 2023 Jun; 141(24):2955-2960. PubMed ID: 36989492
[TBL] [Abstract][Full Text] [Related]
6. Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHV
Burns A; Alsolami R; Becq J; Stamatopoulos B; Timbs A; Bruce D; Robbe P; Vavoulis D; Clifford R; Cabes M; Dreau H; Taylor J; Knight SJL; Mansson R; Bentley D; Beekman R; Martín-Subero JI; Campo E; Houlston RS; Ridout KE; Schuh A
Leukemia; 2018 Feb; 32(2):332-342. PubMed ID: 28584254
[TBL] [Abstract][Full Text] [Related]
7. Integrative epigenomics in chronic lymphocytic leukaemia: Biological insights and clinical applications.
Kulis M; Martin-Subero JI
Br J Haematol; 2023 Feb; 200(3):280-290. PubMed ID: 36121003
[TBL] [Abstract][Full Text] [Related]
8. A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi.
Hoogeboom R; van Kessel KP; Hochstenbach F; Wormhoudt TA; Reinten RJ; Wagner K; Kater AP; Guikema JE; Bende RJ; van Noesel CJ
J Exp Med; 2013 Jan; 210(1):59-70. PubMed ID: 23296468
[TBL] [Abstract][Full Text] [Related]
9. Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL.
Wierzbinska JA; Toth R; Ishaque N; Rippe K; Mallm JP; Klett LC; Mertens D; Zenz T; Hielscher T; Seifert M; Küppers R; Assenov Y; Lutsik P; Stilgenbauer S; Roessner PM; Seiffert M; Byrd J; Oakes CC; Plass C; Lipka DB
Genome Med; 2020 Mar; 12(1):29. PubMed ID: 32188505
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of IgA- and/or IgG-switched chronic lymphocytic leukemia B cells.
Matolcsy A; Casali P; Nádor RG; Liu YF; Knowles DM
Blood; 1997 Mar; 89(5):1732-9. PubMed ID: 9057657
[TBL] [Abstract][Full Text] [Related]
11. Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemia.
Henriques A; Rodríguez-Caballero A; Nieto WG; Langerak AW; Criado I; Lécrevisse Q; González M; Pais ML; Paiva A; Almeida J; Orfao A
PLoS One; 2013; 8(7):e67751. PubMed ID: 23844084
[TBL] [Abstract][Full Text] [Related]
12. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
[TBL] [Abstract][Full Text] [Related]
13. The
Perez-Chacon G; Zapata JM
Front Immunol; 2021; 12():627602. PubMed ID: 33912159
[TBL] [Abstract][Full Text] [Related]
14. Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.
Hervé M; Xu K; Ng YS; Wardemann H; Albesiano E; Messmer BT; Chiorazzi N; Meffre E
J Clin Invest; 2005 Jun; 115(6):1636-43. PubMed ID: 15902303
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
Kn H; Bassal S; Tikellis C; El-Osta A
Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
[TBL] [Abstract][Full Text] [Related]
16. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
[TBL] [Abstract][Full Text] [Related]
17. The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
Yuan C; Chu CC; Yan XJ; Bagnara D; Chiorazzi N; MacCarthy T
PLoS One; 2017; 12(1):e0167602. PubMed ID: 28125682
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact.
Mansouri L; Wierzbinska JA; Plass C; Rosenquist R
Semin Cancer Biol; 2018 Aug; 51():1-11. PubMed ID: 29427646
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications.
Pérez-Carretero C; Hernández-Sánchez M; González T; Quijada-Álamo M; Martín-Izquierdo M; Hernández-Sánchez JM; Vidal MJ; de Coca AG; Aguilar C; Vargas-Pabón M; Alonso S; Sierra M; Rubio-Martínez A; Dávila J; Díaz-Valdés JR; Queizán JA; Hernández-Rivas JÁ; Benito R; Rodríguez-Vicente AE; Hernández-Rivas JM
Int J Cancer; 2020 Nov; 147(10):2780-2792. PubMed ID: 32720348
[TBL] [Abstract][Full Text] [Related]
20. Intraclonal cell expansion and selection driven by B cell receptor in chronic lymphocytic leukemia.
Colombo M; Cutrona G; Reverberi D; Fabris S; Neri A; Fabbi M; Quintana G; Quarta G; Ghiotto F; Fais F; Ferrarini M
Mol Med; 2011; 17(7-8):834-9. PubMed ID: 21541442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]